ReP USP - Resultado da busca

Artigo de periodico
Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck (2008)
Michaluart, P.; Abdallah, K. A.; Lima, F. D.; Smith, R.; Moysés, R. A.; Coelho, V.; Victora, G. D.; Socorro-Silva, A.; Volsi, E. C.; Zárate-Bladés, C. R.; Ferraz, Alberto Rossetti; Barreto, A. K.; Chammas, M. C.; Gomes, R.; Gebrim, E.; Arakawa-Sugueno, L.; Fernandes, K. P.; Lotufo, Paulo Andrade; Cardoso, M. R.; Kalil, J.; Silva, Célio Lopes
Fonte: Cancer Gene Therapy. Unidades: HU, FMRP, FSP
Assuntos: IMUNOTERAPIA, DNA, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MICHALUART, P. et al. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, v. 15, n. 10, p. 676-684, 2008Tradução . . Disponível em: https://doi.org/10.1038/cgt.2008.35. Acesso em: 23 out. 2025.
APA
Michaluart, P., Abdallah, K. A., Lima, F. D., Smith, R., Moysés, R. A., Coelho, V., et al. (2008). Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, 15( 10), 676-684. doi:10.1038/cgt.2008.35
NLM
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2025 out. 23 ] Available from: https://doi.org/10.1038/cgt.2008.35
Vancouver
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2025 out. 23 ] Available from: https://doi.org/10.1038/cgt.2008.35
Trabalho de evento-resumo
Interactions between human dendritic cells and 60 Kda heat shock protein may results in tolerogenic immune response (2007)
Socorro-Silva, A.; Volsi, E. C. F. R.; Victora, G. D.; Caldas, C.; Monteiro, S. M.; Porto, G.; Coelho, V.; Kalil, Jorge
Fonte: Abstracts. Nome do evento: International Congress of Immunology. Unidade: FM
Assuntos: CÉLULAS DENDRÍTICAS, SISTEMA IMUNE, DOENÇAS DO COMPLEXO IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOCORRO-SILVA, A. et al. Interactions between human dendritic cells and 60 Kda heat shock protein may results in tolerogenic immune response. 2007, Anais.. Rio de Janeiro: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 14. . Acesso em: 23 out. 2025.
APA
Socorro-Silva, A., Volsi, E. C. F. R., Victora, G. D., Caldas, C., Monteiro, S. M., Porto, G., et al. (2007). Interactions between human dendritic cells and 60 Kda heat shock protein may results in tolerogenic immune response. In Abstracts (p. 14). Rio de Janeiro: Faculdade de Medicina, Universidade de São Paulo.
NLM
Socorro-Silva A, Volsi ECFR, Victora GD, Caldas C, Monteiro SM, Porto G, Coelho V, Kalil J. Interactions between human dendritic cells and 60 Kda heat shock protein may results in tolerogenic immune response. Abstracts. 2007 ; 14.[citado 2025 out. 23 ]
Vancouver
Socorro-Silva A, Volsi ECFR, Victora GD, Caldas C, Monteiro SM, Porto G, Coelho V, Kalil J. Interactions between human dendritic cells and 60 Kda heat shock protein may results in tolerogenic immune response. Abstracts. 2007 ; 14.[citado 2025 out. 23 ]
Trabalho de evento-resumo
Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial (2007)
Victora, G. D.; Coelho, V. P. C. V.; Socorro-Silva, A.; Volsi, E. C.; Abdallah, K.; Lima, F. D.; Michaluart Junior, P.; Kalil, Jorge; Rodrigues Junior, J. M.; Lima, K. M.; Silva, C. L.
Fonte: Abstracts. Nome do evento: International Congress of Immunology. Unidade: FM
Assuntos: NEOPLASIAS DE CABEÇA E PESCOÇO, CARCINOMA DE CÉLULAS ESCAMOSAS, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTORA, G. D. et al. Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. 2007, Anais.. Rio de Janeiro: Faculdade de Medicina, Universidade de São Paulo, 2007. p. 19. . Acesso em: 23 out. 2025.
APA
Victora, G. D., Coelho, V. P. C. V., Socorro-Silva, A., Volsi, E. C., Abdallah, K., Lima, F. D., et al. (2007). Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. In Abstracts (p. 19). Rio de Janeiro: Faculdade de Medicina, Universidade de São Paulo.
NLM
Victora GD, Coelho VPCV, Socorro-Silva A, Volsi EC, Abdallah K, Lima FD, Michaluart Junior P, Kalil J, Rodrigues Junior JM, Lima KM, Silva CL. Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. Abstracts. 2007 ; 19.[citado 2025 out. 23 ]
Vancouver
Victora GD, Coelho VPCV, Socorro-Silva A, Volsi EC, Abdallah K, Lima FD, Michaluart Junior P, Kalil J, Rodrigues Junior JM, Lima KM, Silva CL. Immune response to heat shock protein 65 and 60 in patients with head and neck cancer vaccinated with DNA-Hsp65 in a phase 1 clinical trial. Abstracts. 2007 ; 19.[citado 2025 out. 23 ]
Trabalho de evento-resumo
Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial (2006)
Victora, G. D.; Socorro-Silva, A.; Volsi, E.; Abdallah, K.; Lima, F. D.; Michaluart Junior, P.; Rodrigues Junior, J. M.; Lima, K. M.; Silva, C. L.; Kalil Filho, J.; Coelho, V.
Nome do evento: European Congress of Immunology. Unidade: FM
Assuntos: VACINAÇÃO (IMUNOLOGIA), CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTORA, G. D. et al. Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. 2006, Anais.. Paris: Faculdade de Medicina, Universidade de São Paulo, 2006. . Acesso em: 23 out. 2025.
APA
Victora, G. D., Socorro-Silva, A., Volsi, E., Abdallah, K., Lima, F. D., Michaluart Junior, P., et al. (2006). Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. In . Paris: Faculdade de Medicina, Universidade de São Paulo.
NLM
Victora GD, Socorro-Silva A, Volsi E, Abdallah K, Lima FD, Michaluart Junior P, Rodrigues Junior JM, Lima KM, Silva CL, Kalil Filho J, Coelho V. Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. 2006 ;[citado 2025 out. 23 ]
Vancouver
Victora GD, Socorro-Silva A, Volsi E, Abdallah K, Lima FD, Michaluart Junior P, Rodrigues Junior JM, Lima KM, Silva CL, Kalil Filho J, Coelho V. Immune reactivity to mycobacterial HSP65 and human HSP60 in cancer patients treated with DNA-HSP65 vaccine in a phase 1 clinical trial. 2006 ;[citado 2025 out. 23 ]

Unidades USP

ReP

Filtros

Autores

Assuntos